bendamustine hydrochloride has been researched along with Erythrophagocytic Lymphohistiocytosis, Familial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geiger, AJ; Sitwala, KV; Yasar, DG | 1 |
1 other study(ies) available for bendamustine hydrochloride and Erythrophagocytic Lymphohistiocytosis, Familial
| Article | Year |
|---|---|
HLH and TET2 Mutation Presenting after First Cycle of CLL Treatment.
Topics: Bendamustine Hydrochloride; Dioxygenases; DNA-Binding Proteins; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphohistiocytosis, Hemophagocytic; Rituximab | 2023 |